Please note this list is only limit to the requests from our direct network in Asia, Europe, and the Middle East. Our strategy is to connect with the international market (China, Japan, Middle East, Europe), and International capital sources. We also provide global clinical trial services. All documents must be in English. 

1.Medical device companies

  • Spinal, Sports medicine, joints, surgical, cardiovascular, neurovascular
  • Class 2 or 3 medical devices
  • Technology leading min 2 years ahead of peer products in the global market
  • CE Mark OR US FDA
  • Have clinical trial reports from reputable hospitals (limit to West Europe/US/China/Australia)
  • Endorsed by leading KOLs in the home country
  • A global patent filed in major markets: US, China, and Europe
  • Sufficient operating cash flow for the next 6-12 months
  • Platforms products are preferred

2. Vaccine companies

  • Vaccine companies or products
  • Clinical trial phase 1, 2, or 3 (have pre-clinical data)
  • Have clinical trial reports from reputable hospitals (limit to West Europe/US/China/Australia)
  • Endorsed by leading KOLs in the home country
  • A global patent filed in major markets: US, China, and Europe
  • Sufficient operating cash flow for the next 6-12 months
  • Platforms products are preferred

3.Innovative drug companies

  • Innovative drug companies or products prefer oncology, especially solid tumor
  • Clinical trial phase 1, 2 (have pre-clinical data)
  • Have clinical trial reports from reputable hospitals (limit to West Europe/US/China/Australia)
  • Endorsed by leading KOLs in the home country
  • A global patent filed in major markets: US, China, and Europe
  • Sufficient operating cash flow for the next 6-12 months
  • Platforms products are preferred

4. Mature life science or medical device companies

  • Stage: mature companies with a proven sales record
  • Location: US, Europe, Asia
  • Size: min 50M USD
Share This